Anti-epidermal growth factor (EGFR) antibody, cetuximab, in patients with stage IV colorectal carcinoma who failed all standard therapy: Final report of an access protocol. Meeting Abstract

cited authors

  • Spitzer, G, Zackon, I, Stella, P, Zehngebot, L, Henderson, C

Publication Date

  • June 1, 2005

webpage

published in

category

start page

  • 282S

end page

  • 282S

volume

  • 23

issue

  • 16

WoS Citations

  • 4

WoS References

  • 0